Anaplastic Lymphoma Kinase (ALK)

Science-Business eXchange
doi 10.1038/scibx.2008.431
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Springer Science and Business Media LLC

Related search

ALK-negative Anaplastic Large Cell Lymphoma

2020English

Status of the Anaplastic Lymphoma Kinase (ALK) Gene in Inflammatory Breast Carcinoma

SpringerPlus
Multidisciplinary
2013English

Development of Anaplastic Lymphoma Kinase (ALK) Inhibitors and Molecular Diagnosis in ALK Rearrangement-Positive Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2014English

Anaplastic Lymphoma Kinase (ALK) Inhibitors for Second-Line Therapy of Non-Small Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2012English

Leukemic Phase of ALK-positive Anaplastic Large Cell Lymphoma

Blood
BiochemistryImmunologyCell BiologyHematology
2013English

Targeting Anaplastic Lymphoma Kinase in Neuroblastoma

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
ImmunologyAllergyMicrobiologyMedicineForensic MedicinePathology
2019English

Targeting High-Risk Pediatric Solid Tumors With CAR T Cells Directed Against ALK (Anaplastic Lymphoma Kinase, CD246)

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Secondary CNS Involvement of ALK-negative Anaplastic Large Cell Lymphoma

American Journal of Hematology
Hematology
2017English

MA26.02 Upfront or Sequential Strategy for New Generation Anaplastic Lymphoma Kinase (ALK) Inhibitors: An Italian Retrospective Study.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy